Contribution of subcutaneous abdominal fat on ultrasonography to carotid atherosclerosis in patients with type 2 diabetes mellitus

Table 3 Relation between abdominal fat and carotid atherosclerosis as determined by multiple linear regression analysis

	Men			Women
	(Adjusted-R² = 0.396)			(Adjusted-R² = 0.262)
Variables	Beta	95% CI	P-value	Beta	95% CI	P-value
Age (years)	0.008	0.006 ~ 0.011	<0.001	0.007	0.004-0.009	<0.001
BMI (kg/m²)	0.007	-0.05 ~ 0.048	0.089	0.009	-0.004 ~ 0.021	0.175
SBP (mmHg)	0.001	0.000 ~ 0.002	0.098	0.001	-0.002 ~ 0.002	0.823
HDL-C (mg/dl)	0.001	-0.002 ~ 0.002	0.748	0.001	-0.002 ~ 0.004	0.424
LDL-C (mg/dl)	0.001	0.000 ~ 0.001	0.028	0.001	0.000 ~ 0.021	0.213
TG (mg/dl)	0.001	0.000 ~ 0.001	0.016	-0.001	0.000 ~ 0.001	0.766
HOMA-IR	0.001	-0.007 ~ 0.008	0.864	-0.006	-0.015 ~ 0.004	0.243
Smoking	-0.001	-0.050 ~ 0.048	0.971	0.005	-0.147 ~ 0.158	0.946
Treatment with statin	0.007	-0.04 ~ 0.053	0.780	0.037	-0.021 ~ 0.094	0.206
Treatment with antihypertensive agents	-0.003	-0.051 ~ 0.046	0.917	-0.036	-0.103 ~ 0.031	0.287
Treatment with TZD	-0.06	-0.135 ~ 0.016	0.122	0.017	-0.089 ~ 0.123	0.75
VFT (mm)	-0.001	-0.006 ~ 0.003	0.569	0.001	-0.006 ~ 0.007	0.835
SFT (mm)	-0.004	-0.005 ~ -0.002	<0.001	-0.002	-0.005 ~ 0.001	0.175

Abbreviations: BMI: body mass index; SBP: systolic blood pressure; HDL-C: high density lipoprotein-cholesterol; LDL-C: low density lipoprotein-cholesterol; TG: triglyceride; HOMA-IR: homeostasis model assessment-insulin resistance; TZD: thiazolidinedione; VFT: visceral fat thickness; SFT: subcutaneous fat thickness.

ISSN: 1475-2840